Top news
No subsidies for obesity drug Wegovy
Patients may continue to pay for obesity drugs themselves. The Dental and Pharmaceutical Benefits Agency (TLV) has rejected subsidies for the obesity drug Wegovy.
SwedenPatients may continue to pay for obesity drugs themselves. The Dental and Pharmaceutical Benefits Agency (TLV) has rejected subsidies for the obesity drug Wegovy.
SwedenYou're up to date in Novo Nordisk Sverige
That's every story in Novo Nordisk Sverige for now.